Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Operating Officer
-
Stock Symbol
-
XLO on Nasdaq
There are no Buy or Sell transactions made by Christopher James Frankenfield since 9/17/2023
Holdings reported by Christopher James Frankenfield for Xilio Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Restricted Stock Units |
77.5K |
$793K |
$10.24 |
Jan 1, 2024 |
Direct |
Common Stock |
|
| Stock Option (right to buy) |
52K |
|
|
Aug 3, 2024 |
Direct |
Common Stock |
|
Transactions reported by Christopher James Frankenfield for Xilio Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.